The healthcare landscape is experiencing a development with the emergence of GLP-1 transdermal systems . These innovative formulations offer a possible approach to delivering glucagon-like peptide-1 therapies for individuals battling the disease . Instead of injections , a simple patch placed to the skin could release a steady dose of the medicatio